Burden of cancer in Malawi; common types, incidence and trends: National population-based cancer registry
© Msyamboza et al; licensee BioMed Central Ltd. 2010
Received: 28 October 2011
Accepted: 16 March 2012
Published: 16 March 2012
Cancer is a leading cause of morbidity and mortality worldwide with a majority of cases and deaths occurring in developing countries. While cancer of the lung, breast, colorectum, stomach and prostate are the most common types of cancer globally, in east and southern Africa these are less common and comprehensive data to inform policies are lacking.
Nationwide cancer registry was conducted between September and October 2010 in Malawi. New cancer cases registered from 2007 to 2010 were identified from hospital and clinic registers of 81 out of 84 health facilities providing cancer diagnosis, treatment or palliative care services. Demographic and cancer data were extracted from registers and case notes using a standard form.
A total of 18,946 new cases of cancer were registered in Malawi from 2007-2010. Of these 55.9% were females, 7.2% were children aged less than 15 years, 76.5% were adults aged 15-59 years and 16.4% were elderly aged 60 years or more. Only 17.9% of the cases had histologically verified diagnosis, 33.2% were diagnosed clinically and 49.6% based on clinical and some investigations. Amongst females, cancer of the cervix was the commonest accounting for 45.4% of all cases followed by Kaposi sarcoma (21.1%), cancer of the oesophagus (8.2%), breast (4.6%) and non-Hodgkin lymphoma (4.1%). In males, Kaposi sarcoma was the most frequent (50.7%) then cancer of oesophagus (16.9%), non-Hodgkin lymphoma (7.8), prostate (4.0%) and urinary bladder (3.7%). Age-standardised incidence rate per 100,000 population for all types of cancer in males increased from 31 in 1999-2002 to 56 in 2007-2010. In females it increased from 29 to 69. Kaposi sarcoma and cancer of the oesophagus, cervical cancer and Kaposi sarcoma were the main causes for the increased incidence in males and females respectively. It was estimated that, annually at least 8,151 new cases of cancer (all types) occur in Malawi.
This study provided data on common types and trends of cancer that could be used to focus prevention, treatment and control interventions in the context of limited resources. The problem of under-reporting and misdiagnosis of cancer cases has been highlighted.
KeywordsCancer Non-communicable diseases Sub-Saharan Africa Malawi
Cancer is a leading cause of morbidity and mortality worldwide. In 2008, globally, there were 12.7 million new cancer cases and 7.6 million cancer deaths (around 13% of all deaths) with 56% of the new cases and 63% of the cancer deaths occurring in developing countries. It is projected that by 2030, the number of new cancer cases and deaths will increase by 69% and 72% to 21.4 million and 13.2 million respectively [1, 2]. While cancer of the lung (12.7%), breast (10.9%), colorectum (9.7%), stomach (7.8%) and prostate (7.2%) are the most common types of cancer globally [1, 2], in sub-Saharan Africa (SSA) these are less common. In eastern and southern Africa (ESA) where HIV prevalence is high, AIDS-defining cancers including Kaposi sarcoma, cervical cancer, and non-Hodgkin lymphoma are the most common. In West Africa, cancer of the liver is the most common [3–6]. Prevalences of risk factors for cancer in ESA are high; HIV 10% or more, human papillomavirus 34%, tobacco smoking and harmful use of alcohol particularly in men 25% and 19% respectively and overweight in women 28% or more [7–9]. Indoor smoke from household use of solid fuels and urban air pollution are other common cancer risk factors in this region . Comprehensive data on the burden and trends of cancer to inform policies, strategies and interventions are lacking in most countries in eastern and southern African region. Between September and October 2010, a nationwide cancer registry was conducted to determine the magnitude, trends of cancer and its challenges in Malawi.
Survey design, sites and data collection
Malawi Cancer Registry was established in 1985 as a population-based cancer registry with the aim of maintaining high quality cancer surveillance system and promoting research on cancer through collaboration. Utilising the cancer registry system, a cross-sectional health facility-based nationwide survey was conducted. All district (secondary), central (tertiary) and main public and private hospitals providing cancer laboratory diagnosis, treatment, palliative care or referral services were eligible and mapped out as survey sites. A total of 84 (70 public, 6 private, 6 research and 2 non-governmental) facilities met the criteria. Of these, 81 (94.4%) consented to take part and data were collected. Three facilities (all international research institutions) refused to take part. The reason for their refusal was that they needed clearance from their headquarters which was not granted. The other three research institutions were local and participated in this study. Cancer cases and deaths were identified from registers in outpatient department (OPD), inpatient wards (all wards available at the facility), clinics (all clinics available), laboratory, pharmacy, theatre and mortuary. Demographic and cancer data on the identified cancer cases or deaths were extracted using a standard form from Malawi Cancer Registry. Data were extracted for period 1 January 2007 to 31 August 2010. Data collection was conducted by trained health workers (nurses and clinical officers) from September to October 2010.
Data were entered, cleaned and analysed using World Health Organisation cancer registry software version 4 (Can Reg4). The software had ability to detect duplicates thereby reducing the risk of double counting of cases that might have visited several hospitals or same hospital at different times. It also had the ability to estimate the age-standardised incidence rates based on age-specific national population data. National population data disaggregated by 5-year age groups and by sex was obtained from the Malawi National Statistics Office (NSO). The NSO data were entered and used to produce age-standardised incidence rates in Can Reg4. The existing data in the Malawi Cancer Registry database were used to produce trends of cancer from 1987-2010.
Ethical approval was granted by the Malawi National Health Sciences Research and Ethics Committee. Written informed consent to extract data from hospital registers and records was obtained from directors of hospitals that participated in the study.
Characteristics of new cases of cancer and methods of diagnosis
Number of registered new cases, method of diagnosis and geographical distribution of cancer in Malawi: 1987-2010
New registered cancer cases:
Method of cancer diagnosis:
Clinical and some investigations
Cancer cases by region:
Common types of cancer in Malawi
Common types of registered new cancer cases by gender and age in Malawi: 2007-2010
Children under 15 years old
Adults aged 15-59 years
Elderly aged 60 years or more
Stomach, intestine, rectum, anus
Age-standardised incidence rate and estimated annual number of registered new cancer cases by gender in Malawi
Age standardised cancer incidence rate per 100,000 population per year
Estimated annual number of new cancer cases
Estimated total annual number of new cancer cases
Stomach, intestine, rectum, anus
Trends of age-standardised incidence
This national cancer registry study demonstrated that cancer is an important public health problem and incidence was increasing in Malawi. Kaposi sarcoma, cancer of the cervix and cancer of the oesophagus were the major cause of the increasing trend. With high HIV prevalence of 10.6% , the increase is Kaposi sarcoma and cervical cancer was in agreement with the findings from other studies [12, 13]. The active case finding was more extensive in this survey providing more complete national data than previously reported.
The introduction and scaling up of free HIV antiretroviral therapy (ART) programme and insecticide-treated bednets (ITN) in 2003 did not seem to have an impact on the trends of Kaposi sarcoma, cervical cancer and Burkitt's lymphoma respectively as suggested by studies from other countries [13, 14]. This could suggest that higher ART and ITN coverages are required to show impact on HIV and malaria related cancers than the current (2010) 65% coverage of estimated population in need of ART and 40% insecticide-treated bed net use in children under the age of five years [11, 15]. For cancer of the oesophagus, it was not known why the trend was increasing. High HIV prevalence was less likely because the association between cancer of the oesophagus and HIV/AIDS is not well established although both may be related to fumonisin, a mycotoxin found in maize . Increase in smoking, consumption of alcohol and maize contaminated with fumonisin could be some of the factors contributing to the increase in incidence of oesophageal cancer [7, 16, 17]. Lung cancer, the world's most frequent cancer in males, is generally reported to be less common in sub-Saharan Africa [3, 18, 19] although tobacco smoking is common with prevalence of at least 25% in men . The reasons for relatively low prevalence of lung cancer in the presence of high prevalence of tobacco smoking in sub-Saharan Africa are unknown. Under-reporting, misdiagnosis, competing high levels of HIV/AIDS related cancers could be the possible explanations [18, 20, 21].
Our findings on the significance of gender and age differences for Kaposi sarcoma, cancer of oesophagus and non-Hodgkin lymphoma being more common in males than females, cancer of the oesophagus in people aged 60 years or more, and Kaposi sarcoma and non-Hodgkin lymphoma, in particular Burkitt's, being the most common cancers in children under 15 years of age were consistent with other studies [22–25]. Two thirds (67.1%) of non-Hodgkin lymphoma cases were children aged less than 15 years old. As countries in sub-Saharan Africa implement universal coverage of ART and ITNs, there would be need to monitor the trends of HIV and malaria related cancers as one way of assessing other public health benefits of these interventions.
The Malawi Ministry of Health, through Sexual and Reproductive Health Unit, implemented a screen-and-treat programme for cervical cancer using visual inspection with acetic acid (VIA) approach. The programme started in 2004 and targeted women aged 30-50 years old. As of June 2011, there were a total of 81 health facilities providing cervical cancer services (50 VIA only, 29 VIA and cryotherapy and 2 VIA, cryotherapy, loop electrosurgical excision procedure (LEEP) and major surgery). Cumulatively, a total of 59,217 women were screened, 5,744 (9.7%) were VIA positive and 1,777 (3.0%) had suspected cervical cancer . This study demonstrated that 12.0% and 32.1% of cervical cancer cases were aged 20-29 years and 50 years or more respectively. This would suggest that the VIA Programme in Malawi could be missing at least 44% of women with cervical cancer. Data on population-based, age-specific prevalence of Human papillomavirus (HPV), the virus that causes cervical cancer is not available in Malawi. However, WHO estimates that the overall HPV prevalence is about 34% . Studies from other countries reported HPV prevalence in women having two peaks, one at 15-29 year age group and the other at 60-69 year age group [28, 29]. This, together with high HIV prevalence could be some of the reasons for cervical cancer occurrence in young and older age groups. Cervical cancer screening is the only established public health cancer screening programme in Malawi. Breast (mammography) and prostate (prostate-specific antigen test and digital rectal examination) cancer screening were available in only one private hospital. This private hospital participated in the study. Lung cancer was not routinely screened. Introduction of other cancer screening services in addition to cervical cancer in public health facilities could enhance early detection and treatment.
This study also revealed that only 18% of the cancer cases had laboratory verified diagnosis. Inadequate laboratory capacity (only one public and one private histology laboratory, all in Blantyre), long waiting time to get histology results, confidence of health workers in diagnosing some cancers clinically, in particular Kaposi sarcoma (the commonest cancer), late presentation of patients to health facility and lack of treatment, in particular, chemotherapy and radiotherapy could be some of the factors leading to low laboratory verified diagnosis. The low level of laboratory verified cases would suggest that the reported number of cancer cases was likely to be under-estimated because of under diagnosis and missing of cancer cases . Current WHO estimates suggest that every year there are at least 2,316 new cases of cervical cancer cases in Malawi  while estimate from this study was 1,236. This illustrated that the reported number of registered new cervical cancer cases was only 53% of the actual problem at the community level. Some of the possible reasons for under-detection of cervical cancer cases could be low coverage of the screening programme (3.7% of the target group) and low specificity of VIA although it is the cost-effective screening method recommended for resource-limited settings and is comparable to Pap smear [27, 30–32]. Despite the under-reporting, population-based cancer registry is the cost-effective method of collecting comprehensive data on cancer that resource-poor countries in sub-Saharan Africa are being encouraged to establish .
About half (52%) of registered new cancer cases (all types of cancer) were from the southern region with central and northern region accounting for 35% and 13% respectively. Population distribution was less likely to be the main reason as distribution was similar in the south and centre at 45% and 42% respectively . The extent of active case finding in this survey was similar in all the regions whereby as many health facilities as possible were visited. Availability of diagnostic services hence less specimen transport cost and waiting time for results, cancer registry office and high HIV prevalence (south 18%, centre 10%, and north 8%) in the southern region were likely to be some of the contributing factors .
Data on lifestyles (tobacco smoking and alcohol consumption) and HIV status were not available. Some of the registers, particularly in public facilities were missing. These were the limitations of this study. These limitations apply to all studies that utilise available health facility data in general. Another limitation of this study was the refusal by three international research institutions to participate in this study. The reason for their refusal was that they had to seek clearance from their headquarters which was not granted. However, all the three international research institutions were housed within the public hospital and were recruiting cases from outpatient department or wards. In addition, all the institutions sent specimens to National Histopathology Laboratory which participated in this study. It was therefore less likely that non-participation of these three international research institutions had significant effect on the results as most of cases were likely to be captured either from public hospital registers where cases were first registered or from histology laboratory where specimens were sent or both. The use of clinical diagnosis only, cancer screening tests such as VIA and prostate specific antigen (PSA) have their own limitations but these limitations were beyond this study. This study only collected and analysed data that were already there. Nevertheless, the comprehensive analysis of the burden of cancer and its challenges demonstrated by this study provided local evidence that could be used to inform policies, strategies and interventions for prevention and control of cancer in Malawi, eastern and southern African region.
Cancer is a public health problem and the trend is increasing in Malawi, a poor country in eastern and southern Africa. Scaling up and/or improving the quality of cervical and breast cancer screening programmes, laboratory verified diagnosis, chemotherapy and radiotherapy treatment and introduction of human papillomavirus vaccine for cervical cancer control could be some of cancer prevention, treatment and control interventions that Malawi and other countries in eastern and southern Africa may consider to strengthen or adopt.
We are grateful to District Health Officers, Directors of Central Hospitals and Directors of Private Hospitals and Research Institutions for allowing their health facilities to participate in the study.
This study was funded by World Health Organisation allotment number AF.MAL.AAG.000.XU.10. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
- World Health Organization International Agency for Research on Cancer (IARC): Globocan 2008 Report. 2008, IARC: Lyon, 2008
- World Health Organization: Cancer fact sheet no. 297. 2011, Geneva: World Health Organization
- Parkin DM, Ferlay J, Hamdi-Cherif M, Sitas F, Thomas J, Wabinga H, Whelan S L: Cancer in Africa: Epidemiology and Prevention. 2003, Lyon, France: lnternational Agency for Research on Cancer
- Casper C: The increasing burden of HIV-associated malignancies in resource-limited regions. Annu Rev Med. 2011, 62: 157-170. 10.1146/annurev-med-050409-103711.PubMedView Article
- Sitas F, Parkin M, Chirenje Z, Stein L, Mqoqi N, Wabinga H: Disease and Mortality in Sub-Saharan Africa. 2006, Washington (DC): World Bank, 2
- Venook AP, Papandreou C, Furuse J, de Guevara LL: The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist. 2010, 15 (Suppl 4): 5-13.PubMedView Article
- Msyamboza KP, Ngwira B, Dzowela T, Mvula C, Kathyola D, Harries AD, Bowie C: The Burden of Selected Chronic Non-Communicable Diseases and Their Risk Factors in Malawi: Nationwide STEPS Survey. PLoS One. 2011, 6 (5): e20316-10.1371/journal.pone.0020316.PubMedPubMed CentralView Article
- Damasceno A, Azevedo A, Silva-Matos C, Prista A, Diogo D, Lunet N: Hypertension prevalence, awareness, treatment, and control in Mozambique: urban/rural gap during epidemiological transition. Hypertension. 2009, 54 (1): 77-83. 10.1161/HYPERTENSIONAHA.109.132423.PubMedView Article
- Nsakashalo-Senkwe M, Siziya S, Goma FM, Songolo P, Mukonka V, Babaniyi O: Combined prevalence of impaired glucose level or diabetes and its correlates in Lusaka urban district, Zambia: a population based survey. Int Arch Med. 2011, 4 (1): 2-10.1186/1755-7682-4-2.PubMedPubMed CentralView Article
- Dalal S, Beunza JJ, Volmink J, Adebamowo C, Bajunirwe F, Njelekela M, Mozaffarian D, Fawzi W, Willett W, Adami HO, Holmes MD: Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol. 2011, 40 (4): 885-901. 10.1093/ije/dyr050.PubMedView Article
- Office Malawi National Statistical: Demographic Health Survey 2010. 2011, National Statistical Office: Zomba
- Mutalima N, Molyneux EM, Johnston WT, Jaffe HW, Kamiza S, Borgstein E, Mkandawire N, Liomba GN, Batumba M, Carpenter LM, Newton R: Impact of infection with human immunodeficiency virus-1 (HIV) on the risk of cancer among children in Malawi - preliminary findings. Infect Agent Cancer. 2010, 5: 5-10.1186/1750-9378-5-5.PubMedPubMed CentralView Article
- Bower M, Palmieri C, Dhillon T: AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis. 2006, 19 (1): 14-19. 10.1097/01.qco.0000200295.30285.13.PubMedView Article
- Geser A, Brubaker G, Draper CC: Effect of a malaria suppression program on the incidence of African Burkitt's lymphoma. Am J Epidemiol. 1989, 129 (4): 740-752.PubMed
- Malawi Ministry of Health: Malawi Antiretroviral treatment Pogramme Quarterly Report: 1st Quarter 2011. Lilongwe. Ministry of Health. 2011
- Williams JH, Grubb JA, Davis JW, Wang JS, Jolly PE, Ankrah NA, Ellis WO, Afriyie-Gyawu E, Johnson NM, Robinson AG, Phillips TD: HIV and hepatocellular and esophageal carcinomas related to consumption of mycotoxin-prone foods in sub-Saharan Africa. Am J Clin Nutr. 2010, 92 (1): 154-160. 10.3945/ajcn.2009.28761.PubMedView Article
- Mlombe Y, Dzamalala C, Chisi J, Othieno-Abinya N: Oesophageal cancer and Kaposi's sarcoma in Malawi: a comparative analysis. Malawi Med J. 2009, 21 (2): 66-68.PubMedPubMed CentralView Article
- Reeve PA: Lung cancer in Malawi: experience of bronchoscopy in Zomba General Hospital. Cent Afr J Med. 1989, 35 (3): 355-358.PubMed
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61 (2): 69-90. 10.3322/caac.20107.PubMedView Article
- Segal I, Ally R, Mitchell H: Gastric cancer in sub-Saharan Africa. Eur J Cancer Prev. 2001, 10 (6): 479-482. 10.1097/00008469-200112000-00001.PubMedView Article
- Banda LT, Parkin DM, Dzamalala CP, Liomba NG: Cancer incidence in Blantyre, Malawi 1994-1998. Trop Med Int Health. 2001, 6 (4): 296-304. 10.1046/j.1365-3156.2001.00707.x.PubMedView Article
- Phipps W, Ssewankambo F, Nguyen H, Saracino M, Wald A, Corey L, Orem J, Kambugu A, Casper C: Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda. PLoS One. 2010, 5 (11): e13936-10.1371/journal.pone.0013936.PubMedPubMed CentralView Article
- Mosam A, Aboobaker J, Shaik F: Kaposi's sarcoma in sub-Saharan Africa: a current perspective. Curr Opin Infect Dis. 2010, 23 (2): 119-123. 10.1097/QCO.0b013e328335b01a.PubMedView Article
- Naresh KN, Raphael M, Ayers L, Hurwitz N, Calbi V, Rogena E, Sayed S, Sherman O, Ibrahim HA, Lazzi S, Mourmouras V, Rince P, Githanga J, Byakika B, Moshi E, Durosinmi M, Olasode BJ, Oluwasola OA, Akang EE, Akenòva Y, Adde M, Magrath I, Leoncini L: Lymphomas in sub-Saharan Africa - what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?. Br J Haematol. 2011, doi: 10.1111/j.1365-2141.2011.08772.x
- Mlotha J, Naidoo S: Oro-facial manifestations of Burkitt's lymphoma: an analysis of 680 cases from Malawi. ADJ. 2011, 66 (2): 77-79.
- Ministry of Health- Sexual and Reproductive Health Services: VIA Programme Report June 2011. Lilongwe, Mininstry of Health. 2011
- World Health Organization: WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre): Summary Report 2010. 2010, Geneva: World Health Organization
- Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M, Hutchinson M, Wacholder S, Harford J, Soliman AS, Burk RD, Schiffman M: The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural nigeria: Implications for screen-and-treat strategies. Int J Cancer. 2011, doi: 10.1002/ijc.26211
- Smith JS, Melendy A, Rana RK, Pimenta JM: Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health. 2008, 43 (4 Suppl): S5-25-e1-41.
- Sahasrabuddhe V, Parham G, Mwanahamuntu M, Vermund S: Cervical Cancer Prevention in Low- and Middle-Income Countries: Feasible, Affordable, Essential. Cancer Prev Res (Phila). 2011,
- Mabeya H, Khozaim K, Liu T, Orango O, Chumba D, Pisharodi L, Carter J, Cu-Uvin S: Comparison of Conventional Cervical Cytology Versus Visual Inspection With Acetic Acid Among Human Immunodeficiency Virus-Infected Women in Western Kenya. Low Genit Tract Dis. 2011,
- Sankaranarayanan R, Nessa A, Esmy PO, Dangou JM: Visual inspection methods for cervical cancer prevention. Best Pract Res Clin Obstet Gynaecol. 2011,
- Okobia MN: Cancer care in sub-Saharan Africa - Urgent Need for Population-based Cancer Registries. Ethiop J Health Dev. 2003, 17 (2): 89-98.
- Office Malawi National Statistical: Population and Housing Census 2008 Zomba. 2008, Office: National Statistical
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.